Cristina R Antonescu Selected Research

Cristina R Antonescu Research Topics

Disease

176	Neoplasms (Cancer) 12/2022 - 01/2002
64	Sarcoma (Soft Tissue Sarcoma) 09/2022 - 08/2002
50	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2022 - 08/2002
17	Carcinoma (Carcinomatosis) 12/2021 - 07/2011
10	Neurofibrosarcoma (MPNST) 01/2022 - 07/2009
9	Neoplasm Metastasis (Metastasis) 01/2022 - 08/2002
9	Hemangiosarcoma (Angiosarcoma) 01/2022 - 05/2005
9	Synovial Sarcoma (Synovioma) 01/2021 - 02/2002
8	Leiomyosarcoma 01/2022 - 12/2012
8	Melanoma (Melanoma, Malignant) 01/2018 - 05/2003
8	Necrosis 01/2018 - 03/2005
8	Liposarcoma 07/2016 - 03/2005
7	Carcinogenesis 12/2022 - 03/2004
7	Ewing Sarcoma (Sarcoma, Ewing) 01/2022 - 10/2014
6	Disease Progression 01/2022 - 05/2005
5	Perivascular Epithelioid Cell Neoplasms 01/2022 - 02/2010
5	Genetic Translocation (Chromosomal Translocation) 11/2020 - 08/2002
4	Mesothelioma 10/2022 - 11/2020
4	Endometrial Stromal Sarcoma 01/2022 - 01/2021
4	Osteosarcoma (Osteogenic Sarcoma) 01/2019 - 03/2005
4	Neurofibromatosis 1 (Neurofibromatosis Type I) 04/2016 - 04/2005
3	Anemia 01/2022 - 01/2019
3	Adenocarcinoma 01/2021 - 01/2015
3	Chondrosarcoma 01/2020 - 03/2009
3	Rhabdomyosarcoma 01/2019 - 01/2016
3	Dermatofibrosarcoma 01/2018 - 08/2002
3	Clear Cell Sarcoma 04/2017 - 09/2006
2	Adamantinoma 09/2022 - 09/2015
2	Glomus Tumor (Glomus Tumors) 01/2022 - 01/2020
2	Exanthema (Rash) 01/2022 - 01/2022
2	Hypophosphatemia 01/2022 - 01/2022
2	Edema (Dropsy) 01/2022 - 01/2019
2	Salivary Gland Neoplasms (Salivary Gland Cancer) 10/2021 - 10/2017
2	Bone Resorption 04/2021 - 03/2005
2	Malignant Mesothelioma 01/2021 - 07/2017
2	Myoepithelioma 11/2020 - 10/2019
2	Angiomatoid Fibrous Histiocytoma 11/2020 - 04/2017
2	Fibrosarcoma 10/2020 - 01/2017
2	Myopericytoma 01/2020 - 11/2013
2	Fever (Fevers) 01/2019 - 01/2018

Drug/Important Bio-Agent (IBA)

43	RNA (Ribonucleic Acid)IBA 11/2022 - 05/2003
43	Imatinib Mesylate (Gleevec)FDA Link 01/2022 - 08/2002
26	Phosphotransferases (Kinase)IBA 01/2022 - 10/2005
19	DesminIBA 11/2022 - 04/2005
19	Keratins (Keratin)IBA 09/2022 - 11/2002
18	Biological ProductsIBA 01/2022 - 01/2002
17	Proteins (Proteins, Gene)FDA Link 12/2022 - 11/2002
17	S100 Proteins (S 100 Protein)IBA 01/2022 - 10/2003
17	Transcription Factors (Transcription Factor)IBA 01/2021 - 11/2002
10	Tyrosine Kinase InhibitorsIBA 01/2022 - 03/2007
8	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 04/2005
8	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2017 - 05/2003
6	Cyclin D1IBA 01/2022 - 12/2017
6	Oncogene Proteins (Oncogene Protein)IBA 01/2021 - 08/2011
6	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2013 - 04/2005
6	Sunitinib (Sutent)FDA Link 05/2012 - 10/2006
5	Pharmaceutical PreparationsIBA 01/2021 - 07/2007
5	Messenger RNA (mRNA)IBA 01/2020 - 12/2016
5	CollagenIBA 12/2018 - 08/2002
5	AntigensIBA 03/2009 - 02/2002
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2005
4	SynaptophysinIBA 01/2022 - 06/2015
4	Estrogen ReceptorsIBA 01/2022 - 01/2018
4	Progesterone Receptors (Progesterone Receptor)IBA 10/2021 - 01/2018
4	tyrosine receptor (receptor, tyrosine)IBA 10/2020 - 02/2008
4	Mucin-1 (CA 15-3 Antigen)IBA 12/2019 - 12/2002
4	Sorafenib (BAY 43-9006)FDA Link 01/2019 - 08/2007
4	Complementary DNA (cDNA)IBA 06/2013 - 11/2002
4	Sirolimus (Rapamycin)FDA Link 04/2013 - 02/2010
4	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2013 - 02/2002
3	AsbestosIBA 10/2022 - 07/2017
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022 - 03/2015
3	Polycomb Repressive Complex 2IBA 01/2022 - 04/2016
3	binimetinibIBA 01/2022 - 03/2015
3	MART-1 AntigenIBA 01/2022 - 10/2018
3	Calmodulin-Binding Proteins (Caldesmon)IBA 10/2021 - 01/2018
3	Anaplastic Lymphoma KinaseIBA 01/2021 - 01/2016
3	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 11/2020 - 07/2015
3	Cathepsin KIBA 11/2019 - 01/2016
3	palbociclibIBA 01/2017 - 06/2013
3	Monoclonal AntibodiesIBA 12/2016 - 02/2002
3	AntibodiesIBA 02/2007 - 03/2004
2	NivolumabIBA 01/2022 - 01/2018
2	CreatinineIBA 01/2022 - 01/2018
2	trans-sodium crocetinate (crocetin)IBA 01/2022 - 04/2013
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022 - 01/2018
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2017
2	ChromograninsIBA 11/2021 - 11/2021
2	ChromatinIBA 01/2021 - 01/2019
2	SMARCB1 ProteinIBA 10/2020 - 06/2014
2	B7-H1 AntigenIBA 01/2020 - 01/2017
2	Proto-Oncogene Proteins c-etsIBA 01/2020 - 07/2014
2	ParaffinIBA 01/2020 - 04/2005
2	Protein Kinases (Protein Kinase)IBA 10/2019 - 01/2019
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2019 - 01/2018

Therapy/Procedure

57	Therapeutics 01/2022 - 08/2002
19	Drug Therapy (Chemotherapy) 06/2020 - 11/2004
7	Radiotherapy 06/2018 - 12/2011
5	Immunotherapy 01/2019 - 02/2002
3	Aftercare (After-Treatment) 02/2009 - 12/2004